Investasi
Fitur
BiayaKeamanan
Akademi
Lainnya
Pluang+

Bandingkan Harga & Kinerja Elang Mahkota Teknologi Tbk. (EMTK) vs Organon Pharma Indonesia Tbk. (SCPI)

Elang Mahkota Teknologi Tbk.Trading
Organon Pharma Indonesia Tbk.Trading

Kinerja harga (24 Jam Terakhir)

Statistik utama

Perbedaan Elang Mahkota Teknologi Tbk. dan Organon Pharma Indonesia Tbk.: Elang Mahkota Teknologi Tbk. diperdagangkan di Rp500 (kapitalisasi pasar 30,71 T, volume 24 jam 52,1 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Elang Mahkota Teknologi Tbk. jauh lebih besar — sekitar 294,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.

EMTKSCPI
Kapitalisasi Pasar
30,71 T104,4 M
Volume
52,1 jt
Lot
520,97 rb
Perputaran
25,95 M
Harga Rata-rata
498,1
Nilai Transaksi
25,95 M
Harga Ekuilibrium Indikatif
500
Volume Ekuilibrium Indikatif
39,77 rb

Perbandingan imbal hasil

Imbal hasil berjalan pada periode standar

Berita terkini

Berita terbaru kedua aset

EMTK
Lihat detail
SCPI
Lihat detail

Tentang Elang Mahkota Teknologi Tbk.

PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.

Selengkapnya di halaman EMTK

Tentang Organon Pharma Indonesia Tbk.

PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.

Selengkapnya di halaman SCPI